For instance, interactions between myeloma cells and MSPCs dramatically increase expressions of VEGF and FGF, two important angiogenic cytokines in MM.222,223 (Fig. 6.1) and bone marrow angiogenesis is a predictor of poor survival in patients with newly diagnosed myeloma.225. Here, VEGFA is linked to plasma cell myeloma.